Clinical Trial Update: Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 results for Lorecivivint (SM04690) in knee osteoarthritis report patient-reported and radiographic outcomes; results were posted on 2026-02-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Lorecivivint (SM04690)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2026-02-13